Medical/Pharmaceuticals

Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation

IRVINE, Calif., Nov. 13, 2024 /PRNewswire/ -- Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of California against Qiagen GmbH (Qiagen) alleging that Qiagen has...

2024-11-13 00:54 1155

The Sigourney Award-2024 Recipients Honored For Outstanding Work Advancing Psychoanalytic Principles Globally

Four Recipients' Work From Israel, Sweden, Canada and South Africa Earns The Sigourney Award-2024 SEATTLE, Nov. 12, 2024 /PRNewswire/ -- The Sigourney Award Trust annually recognizes outstanding work that advances psychoanalytic thought and principles throughout the world.Robin A. Deutsch, PhD a...

2024-11-12 22:20 1143

Hospital Sant Pau and Huawei join forces to accelerate digital transformation in healthcare

BARCELONA, Spain, Nov. 12, 2024 /PRNewswire/ -- Industry Leaders from Hospital de Sant Pau and Huawei today outlined a vision of how digital technology can make hospitals more efficient and improve patients' lives. The speakers shared their though...

2024-11-12 22:04 1124

Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders

Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they pertain to neurodegenerative disorders MORRISVILLE, N.C., Nov. 12, 2024 /PRNewswire/ -- Metabolon, Inc....

2024-11-12 22:00 1131

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

* Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. * Chime Biologics will leverage its CMC expertise in biologics to manage Antibody Intermediate, ADC Drug Substance and Drug P...

2024-11-12 21:15 1321

Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

-Phase III trial enrolled a total of 480 patients with moderate to severe acne -Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III c...

2024-11-12 19:30 1348

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

* After two weeks of treatment, GZR18 tablets resulted in an average weight reduction of up to 4.16%, with continued weight loss observed even after discontinuation. * The pharmacokinetic profile supports a once-daily oral dosing regimen for GZR18 tablets. * The safety and tolerability of G...

2024-11-12 19:00 1154

2024 Tsingke High-Impact Literature Compilation - Gene Synthesis

BEIJING, Nov. 12, 2024 /PRNewswire/ -- Tsingke  has delivered high-quality biotechnology services and products to nearly 300,000 users globally. The number of high-level academic papers published using Tsingke's products and services has grown steadily year after year, ...

2024-11-12 18:09 947

Tsingke Successfully Showcases Innovations at BIO-Europe 2024

BEIJING, Nov. 12, 2024 /PRNewswire/ -- Tsingke proudly concluded its participation in BIO-Europe 2024, held fromNovember 4 to 6 inStockholm, Sweden. As one of the premier global events for the biotechnology, pharmaceutical, and investment sectors, over 5,500 attendees ...

2024-11-12 17:07 923

World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R)

- Patent Covers Invention of Treatment Drug and Prophylactic Drug for Lowering Cardiac Disorder Markers in Dogs as Well as Their Manufacturing Methods - TOKYO, Nov. 12, 2024 /PRNewswire/ -- Scarecrow Incorporated, based in Tokyo's Shibuya Ward, is pleased to announce that it has acquired the worl...

2024-11-12 14:00 1185

WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

SHANGHAI, Nov. 11, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Glo...

2024-11-12 08:00 1093

PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection withhigher throughput for efficient and accurate diagnosis. SAN ANTONIO, Nov. 11, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the multiplexed urinary tract infection detection ind...

2024-11-11 23:00 1190

HoneyNaps AI Diagnostic Medical Software as Featured in International Journal "Digital Health"

- Published clinical study on sleep apnea patients in the prestigious journal Digital Health - Clinical research on HoneyNaps SOMNUM validates its clinical efficacy BOSTON, Nov. 11, 2024 /PRNewswire/ -- Medical AI company HoneyNaps has published a paper demonstrating the clinical value and effic...

2024-11-11 22:00 900

Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.

Acquisition Strengthens Lakeside's Pharmaceutical Logistics Capabilities in China, Projected to Add US$7 Million in Annual Revenue ITASCA, Ill., Nov. 11, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain s...

2024-11-11 21:45 1475

DermRays Revolutionizing At-Home Laser Hair Removal with Innovative New Products

PLEASANTON, Calif., Nov. 11, 2024 /PRNewswire/ -- As anticipation grows around  DermRays' latest developments, industry insiders are abuzz with speculation about the future direction of the company's product line. Whether through a potential upgrade to theV8S Pro

2024-11-11 21:00 772

Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future

Members of the media are invited to register here . SINGAPORE, Nov. 11, 2024 /PRNewswire/ -- The 4th edition Future of Health A...

2024-11-11 20:56 1763

Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes

* Diabetes Singapore and GSK aim to enhance awareness and improve lives affected by diabetes through educational talks and activities on World Diabetes Day * 1 in 3 people will get shingles in their lifetime; People with diabetes are 38% more likely to contract shingles[1] * People with dia...

2024-11-11 20:47 1244

Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe

Highlights: * Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis * Orphan Designation offers 10 years of market exclusivity in Europe upon product approval, along with additional regulat...

2024-11-11 20:30 1005

ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults

* Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline of -11.15%, -13.22%, -14.25%, -17.29%, and -17.78%, respectively, with the placebo group at -0....

2024-11-11 19:36 1168

HKBN x INDICAID Introduce Hong Kong's First At-Home Health Test Monthly Subscription Service

HKBN further expands footprint in medical services HONG KONG, Nov. 11, 2024 /PRNewswire/ -- Hong Kong Broadband Network Limited ("HKBN") has partnered with renowned at-home health test brand, INDICAID, to provide HKBN customers with an innovative healthcare subscription service featuring a varie...

2024-11-11 16:06 1221
12345678 ... 610